These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 20217906)

  • 1. DNA 'caps' offer target for heart drugs.
    Harv Heart Lett; 2010 Jan; 20(5):7. PubMed ID: 20217906
    [No Abstract]   [Full Text] [Related]  

  • 2. Expanding the concept of telomere dysfunction in cardiovascular disease.
    van der Harst P; van Veldhuisen DJ; Samani NJ
    Arterioscler Thromb Vasc Biol; 2008 May; 28(5):807-8. PubMed ID: 18421006
    [No Abstract]   [Full Text] [Related]  

  • 3. Telomere biology and cardiovascular disease.
    Fuster JJ; Andrés V
    Circ Res; 2006 Nov; 99(11):1167-80. PubMed ID: 17122447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomere biology in cardiovascular disease: the TERC-/- mouse as a model for heart failure and ageing.
    Wong LS; Oeseburg H; de Boer RA; van Gilst WH; van Veldhuisen DJ; van der Harst P
    Cardiovasc Res; 2009 Feb; 81(2):244-52. PubMed ID: 19047341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomeres and cardiovascular disease: does size matter?
    Serrano AL; Andrés V
    Circ Res; 2004 Mar; 94(5):575-84. PubMed ID: 15031270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomere length and cardiovascular risk factors in a middle-aged population free of overt cardiovascular disease.
    Bekaert S; De Meyer T; Rietzschel ER; De Buyzere ML; De Bacquer D; Langlois M; Segers P; Cooman L; Van Damme P; Cassiman P; Van Criekinge W; Verdonck P; De Backer GG; Gillebert TC; Van Oostveldt P;
    Aging Cell; 2007 Oct; 6(5):639-47. PubMed ID: 17874998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Short telomere length a marker of premature vascular aging].
    Nilsson PM; Fyhrquist F
    Lakartidningen; 2007 Sep 26-Oct 2; 104(39):2801-5. PubMed ID: 17958006
    [No Abstract]   [Full Text] [Related]  

  • 8. [Some pathogenetic characteristics of the development of circulatory insufficiency in the aged and the principles of treating it with cardiac glycosides].
    Morozov KA; Slupskiĭ NN; Goriainova AN; Koriakin NN
    Ter Arkh; 1974; 46(12):25-33. PubMed ID: 4454017
    [No Abstract]   [Full Text] [Related]  

  • 9. Shared environmental factors associated with telomere length maintenance in elderly male twins.
    Huda N; Tanaka H; Herbert BS; Reed T; Gilley D
    Aging Cell; 2007 Oct; 6(5):709-13. PubMed ID: 17725691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial dysfunction and cardiovascular disease.
    Sherman DL; Loscalzo J
    Cardiologia; 1997 Feb; 42(2):177-87. PubMed ID: 9090161
    [No Abstract]   [Full Text] [Related]  

  • 11. Translating molecular target into drug therapy in cardiovascular disease.
    Bril A; Avkiran M
    Curr Opin Pharmacol; 2008 Apr; 8(2):111-3. PubMed ID: 18294914
    [No Abstract]   [Full Text] [Related]  

  • 12. Assessment of endothelial function: implications for hypertension and cardiovascular disorders.
    Butt M; Dwivedi G; Khair O; Lip GY
    Expert Rev Cardiovasc Ther; 2009 Jun; 7(6):561-3. PubMed ID: 19505269
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cardiovascular pharmacology (VI). The current validity of old drugs: digoxin].
    Martín Luengo C; Arribas Jiménez A; Santos Rodríguez I; Castaño Bazo L; Sánchez López JL
    Rev Esp Cardiol; 1994 Nov; 47(11):754-67. PubMed ID: 7800906
    [No Abstract]   [Full Text] [Related]  

  • 14. Prognostic value of heart rate in cardiovascular disease.
    Sukonthasarn A
    J Med Assoc Thai; 2007 Nov; 90(11):2538-40. PubMed ID: 18181347
    [No Abstract]   [Full Text] [Related]  

  • 15. Oxidative stress and cardiovascular injury: Part II: animal and human studies.
    Griendling KK; FitzGerald GA
    Circulation; 2003 Oct; 108(17):2034-40. PubMed ID: 14581381
    [No Abstract]   [Full Text] [Related]  

  • 16. Hyperdynamic beta-adrenergic circulatory state. Increased beta-receptor responsiveness.
    Frohlich ED; Tarazi RC; Dustan HP
    Arch Intern Med; 1969 Jan; 123(1):1-7. PubMed ID: 5761734
    [No Abstract]   [Full Text] [Related]  

  • 17. [Endothelin. II. The role of endothelin in the pathogenesis of disease].
    Siminiak T; Wysocki H
    Przegl Lek; 1994; 51(12):527-30. PubMed ID: 7746891
    [No Abstract]   [Full Text] [Related]  

  • 18. Nicotinamide adenine dinucleotide phosphate oxidase: a promiscuous therapeutic target for cardiovascular drugs?
    Muzaffar S; Shukla N; Jeremy JY
    Trends Cardiovasc Med; 2005 Nov; 15(8):278-82. PubMed ID: 16297764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Can endothelium be treated with drugs?].
    Fyhrquist F
    Duodecim; 1993; 109(20):1841-7. PubMed ID: 7737007
    [No Abstract]   [Full Text] [Related]  

  • 20. Frontiers in research reviews: arterial function: introduction.
    McGrath BP; Laurent S
    Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):645-6. PubMed ID: 17581223
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.